In the traditional payment examination method, a clinical institution challenges a prescription and prescribes and pays for that drug to your patient at an coverage pharmacy, etc., and afterwards the examination ask for for the clinical practice is manufactured to the assessment payment establishment. Nonetheless, it is actually not possible to evaluate the suitability of the appliance contents upfront for healthcare institutions. Moreover, the insured / insurance provider (health insurance Affiliation, and many others.) that bears the expense of prescription drugs is just not thoroughly knowledgeable about information on drugs for instance efficacy and rate, and is particularly fully educated with regard to the existence of various alternatives. It is commonly not performed. This is why, the selection of medicines is completely remaining to your judgment of a healthcare establishment, and it really is hard to workout the correct to choose medicines as a price bearer in addition to a client.
Really should your professional medical health practitioner requirements the pharmacist to provide you with a specific brand of medication, they have got to exactly Notice this or sign-up the Place shipped.
Notice: It is commonly recommended that to assist cut down the amount of medication problems, prescription building really should be a hundred% English, without having Latin abbreviations. I will educate you The 2 and enable you to arrive at a decision.
In its place, notify the clinical institution, and really encourage the healthcare establishment to reselect prescription material, Pharmaceutical prescription information inquiry / distribution process characterised by comprising
Existing Assignee (The stated assignees might be inaccurate. Google hasn't carried out a authorized Examination and makes no illustration or guarantee as into the accuracy from the listing.)
システムの運用段階では、以下の処理をリアルタイムで実施する。すなわち、個々の診療行為に際して保健医療機関からの処方医薬品の保険適用の可否の問い合わせが通信回線を介して行われ、この問い合わせを前述の審査支払機関及び保険者の入力情報や指定条件に照らし合わせて、審査支払機関及び保険者が保険適用を却下しないか否かを判定し結果を医療機関に配信し、図６に示されるような入出力画面によって医療機関の端末に表示される。尚、判定の結果、問い合わせ内容が審査支払機関及び保険者の入力情報や指定条件に適合しない場合には、これらを満たす医薬品群を検索・同定し、医療機関に配信する。併せて、指定条件を満たした医薬品については、医療機関や被保険者の住所の近くに存在する保険薬局数軒での当該医薬品の取扱情報・在庫情報を保険薬局のデータベースにアクセスし確認を行う。また、保険薬局が、医療機関が発行した処方箋に記されている医薬品の保険適用につき照会を行う場合には、処方箋発行医療機関との照会履歴の有無、結果について配信する。
contain the possible of remaining abused, and that can cause properly staying threats from Damaging effects if taken improperly,
It truly is an object on the existing creation to supply a prescription information inquiry / distribution method for prescription information that allows medical establishments / insurance pharmacies to preferentially adopt the choice medicines from other possibilities. 前記課題を解決するための本発明は、以下の各部から構成されることを特徴とする
It really is made up of assumed health-related fee details calculated for each personal injury and symptom categorized according to scenario, drug price common of used drugs, insurance policies factors, other details needed for evaluation of clinical rate specifics, and many others. Pharmaceutical prescription information inquiry and distribution procedure.
Therefore, even though retaining the fairness of obtaining health-related solutions, the insured / insurance provider / evaluation / payment institution has the opportunity to select a drug that may be considered desirable in the viewpoint of efficiency, selling price, and so forth. Is not furnished adequate. Hence, the trouble in the existing creation is that the insured human being / insurance provider or evaluation / payment establishment wants to prescribe the strongest prescription among choices when keeping read more the fairness of obtaining health care expert services in Japan's professional medical insurance coverage program.
The prescription should be signed through the prescriber by his / her hand. His/her tackle and registration variety definitely ought to be organized in the situation of perilous and actions-forming medicines.
Whenever a prescription suggested medicine is chosen by a professional medical establishment, the dealing with status / stock standing at a close-by insurance pharmacy is verified and the result is notified.
Consider therapy modification - data display that the desired agents might interact with one another in a very clinically-major manner and patient-specific evaluation have to be performed to determine regardless of whether the advantages of concomitant therapy outweigh the risks. Unique steps have to be taken in order to comprehend the advantages and/or decrease toxicity of concomitant use. Prevent combination - details show that the required agents may possibly communicate with one another within a clinically-sizeable fashion and the chance usually outweighs any probable benefit. Concurrent use of these agents is normally considered contraindicated. Test Interactions - Listing of assay interferences when relevant
図１は、本発明の医薬品処方情報照会・配信方法を活用したビジネスモデルの一例の概略を示す図面であり、図２は、当該ビジネスモデルをより具体的に示す図面であり、図３は、情報システム構成の一例を示す図面であり、図４は、情報照会・判定の一例を示すフローチャートであり、図５は、本発明の医薬品処方情報照会・配信のための情報システム内のデータファイルの一例を示す図面であり、図６は、当該情報システムと接続した医療機関の端末の入出力イメージの一例を示す図である。